An Phat Bioplastics（AAA）株式概要An Phat Bioplastics Joint Stock Company は、その子会社とともに、ベトナム、シンガポール、米国、韓国、そして国際的にプラスチック製品の生産と取引を行っている。 詳細AAA ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績5/6財務の健全性6/6配当金2/6報酬株価収益率（ 5.8 x） VN市場（ 11.1 x）を下回っています。過去1年間で収益は112.4%増加しました リスク分析4.26%の配当はフリーキャッシュフローで十分にカバーされていない すべてのリスクチェックを見るAAA Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₫Current Price₫7.04k60.1% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture015t2016201920222025202620282031Revenue ₫12.4tEarnings ₫654.0bAdvancedSet Fair ValueView all narrativesAn Phat Bioplastics Joint Stock Company 競合他社South Basic ChemicalsSymbol: HOSE:CSVMarket cap: ₫2.9tDongNai Plastic ConstructionSymbol: HNX:DNPMarket cap: ₫2.7tDong Phu RubberSymbol: HOSE:DPRMarket cap: ₫3.6tAn Phat HoldingsSymbol: HOSE:APHMarket cap: ₫1.4t価格と性能株価の高値、安値、推移の概要An Phat Bioplastics過去の株価現在の株価₫7,040.0052週高値₫8,970.0052週安値₫6,650.00ベータ0.821ヶ月の変化0.28%3ヶ月変化-9.86%1年変化-2.22%3年間の変化-35.41%5年間の変化-49.55%IPOからの変化-79.13%最新ニュースReported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₫2.22t (down 42% from 1Q 2025). Net income: ₫153.7b (up 240% from 1Q 2025). Profit margin: 6.9% (up from 1.2% in 1Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Vietnam.お知らせ • Apr 04An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026, at 09:00 SE Asia Standard Time. Location: head ofice - lot cni1+cn12, an dong industrial-, cluster, nam sach commune, hai phong city VietnamReported Earnings • Jan 29Full year 2025 earnings released: EPS: ₫947 (vs ₫964 in FY 2024)Full year 2025 results: EPS: ₫947. Revenue: ₫11t (down 16% from FY 2024). Net income: ₫372.9b (up 1.2% from FY 2024). Profit margin: 3.5% (up from 2.9% in FY 2024). The increase in margin was driven by lower expenses.Reported Earnings • Nov 01Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₫2.37t (down 26% from 3Q 2024). Net income: ₫117.6b (up 439% from 3Q 2024). Profit margin: 5.0% (up from 0.7% in 3Q 2024). The increase in margin was driven by lower expenses.New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 4.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.0% net profit margin).Reported Earnings • Jul 31Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: ₫2.31t (down 17% from 2Q 2024). Net income: ₫121.3b (down 11% from 2Q 2024). Profit margin: 5.3% (up from 4.9% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.最新情報をもっと見るRecent updatesReported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₫2.22t (down 42% from 1Q 2025). Net income: ₫153.7b (up 240% from 1Q 2025). Profit margin: 6.9% (up from 1.2% in 1Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Vietnam.お知らせ • Apr 04An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026, at 09:00 SE Asia Standard Time. Location: head ofice - lot cni1+cn12, an dong industrial-, cluster, nam sach commune, hai phong city VietnamReported Earnings • Jan 29Full year 2025 earnings released: EPS: ₫947 (vs ₫964 in FY 2024)Full year 2025 results: EPS: ₫947. Revenue: ₫11t (down 16% from FY 2024). Net income: ₫372.9b (up 1.2% from FY 2024). Profit margin: 3.5% (up from 2.9% in FY 2024). The increase in margin was driven by lower expenses.Reported Earnings • Nov 01Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₫2.37t (down 26% from 3Q 2024). Net income: ₫117.6b (up 439% from 3Q 2024). Profit margin: 5.0% (up from 0.7% in 3Q 2024). The increase in margin was driven by lower expenses.New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 4.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.0% net profit margin).Reported Earnings • Jul 31Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: ₫2.31t (down 17% from 2Q 2024). Net income: ₫121.3b (down 11% from 2Q 2024). Profit margin: 5.3% (up from 4.9% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.New Risk • Jun 01New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.Upcoming Dividend • May 23Upcoming dividend of ₫300 per shareEligible shareholders must have bought the stock before 30 May 2025. Payment date: 20 June 2025. The company last paid an ordinary dividend in June 2014. The average dividend yield among industry peers is 3.8%.New Risk • May 01New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 3.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.New Risk • Apr 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₫2.45t (US$93.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Apr 09Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₫6,410, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total loss to shareholders of 63% over the past three years.お知らせ • Apr 09An Phat Bioplastics Joint Stock Company, Annual General Meeting, Apr 28, 2025An Phat Bioplastics Joint Stock Company, Annual General Meeting, Apr 28, 2025, at 09:00 SE Asia Standard Time. Location: lot cn11-, cn12 an dong industrial park, nam sach town, nam sach district, hai duong province., VietnamReported Earnings • Apr 08Full year 2024 earnings released: EPS: ₫964 (vs ₫651 in FY 2023)Full year 2024 results: EPS: ₫964 (up from ₫651 in FY 2023). Revenue: ₫13t (up 1.3% from FY 2023). Net income: ₫368.6b (up 48% from FY 2023). Profit margin: 2.9% (up from 2.0% in FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.Reported Earnings • Jan 30Full year 2024 earnings released: EPS: ₫947 (vs ₫757 in FY 2023)Full year 2024 results: EPS: ₫947 (up from ₫757 in FY 2023). Revenue: ₫13t (up 1.3% from FY 2023). Net income: ₫361.8b (up 25% from FY 2023). Profit margin: 2.8% (up from 2.3% in FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 30Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: ₫3.19t (down 9.5% from 3Q 2023). Net income: ₫21.8b (down 78% from 3Q 2023). Profit margin: 0.7% (down from 2.8% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Sep 27Standing Deputy General Director recently sold ₫2.0b worth of stockOn the 20th of September, Thoan Tran sold around 200k shares on-market at roughly ₫10,000 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.お知らせ • Sep 12An Phat Bioplastics Joint Stock Company (HOSE:AAA) agreed to acquire additional 15.3% stake in Hanoi Plastics Joint Stock Company (HOSE:NHH) from An Phat Holdings Joint Stock Company (HOSE:APH).An Phat Bioplastics Joint Stock Company (HOSE:AAA) agreed to acquire additional 15.3% stake in Hanoi Plastics Joint Stock Company (HOSE:NHH) from An Phat Holdings Joint Stock Company (HOSE:APH) on September 10, 2024. An Phat Holdings Joint Stock Company is selling 11,160,308 shares of Hanoi Plastics Joint Stock Company. An Phat Bioplastics Joint Stock Company will hold 45,732,882 shares equivalent to 62.75% stake in Hanoi Plastics Joint Stock Company. The transaction has been approved by the board of An Phat Holdings Joint Stock Company and An Phat Bioplastics Joint Stock Company.Reported Earnings • Aug 02Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₫2.78t (flat on 2Q 2023). Net income: ₫119.4b (up 386% from 2Q 2023). Profit margin: 4.3% (up from 0.9% in 2Q 2023).Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: ₫2.96t (down 18% from 1Q 2023). Net income: ₫134.7b (up 88% from 1Q 2023). Profit margin: 4.5% (up from 2.0% in 1Q 2023). The increase in margin was driven by lower expenses.お知らせ • Apr 28An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 27, 2024An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 27, 2024, at 02:00 Coordinated Universal Time. Location: Lot CN11-CN12, An Dong Industrial Cluster, Nam Sach town, Nam Sach disitrct Hai Duong Province VietnamReported Earnings • Feb 02Full year 2023 earnings released: EPS: ₫761 (vs ₫433 in FY 2022)Full year 2023 results: EPS: ₫761 (up from ₫433 in FY 2022). Revenue: ₫13t (down 18% from FY 2022). Net income: ₫290.9b (up 91% from FY 2022). Profit margin: 2.3% (up from 1.0% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Reported Earnings • Nov 02Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: ₫3.53t (up 7.6% from 3Q 2022). Net income: ₫99.0b (up 24% from 3Q 2022). Profit margin: 2.8% (up from 2.4% in 3Q 2022). The increase in margin was driven by higher revenue.Reported Earnings • Aug 03Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: ₫2.79t (down 39% from 2Q 2022). Net income: ₫43.0b (down 50% from 2Q 2022). Profit margin: 1.5% (down from 1.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Reported Earnings • Apr 30First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: ₫3.62t (down 10% from 1Q 2022). Net income: ₫53.9b (down 39% from 1Q 2022). Profit margin: 1.5% (down from 2.2% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Feb 01Full year 2022 earnings released: EPS: ₫407 (vs ₫994 in FY 2021)Full year 2022 results: EPS: ₫407 (down from ₫994 in FY 2021). Revenue: ₫15t (up 16% from FY 2021). Net income: ₫155.7b (down 46% from FY 2021). Profit margin: 1.0% (down from 2.2% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Board Change • Nov 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Nghia Phan was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Aug 25an Phat Bioplastics Joint Stock Company Announces Relocation of Representative OfficeOn August 22, 2022, the Board of Directors of An Phat Bioplastics Joint Stock Company approved the relocation of representative office as follows: Address before change: B9, No.6/106 Hoang Quoc Viet, Nghia Do ward, Cau Giay district, Ha Noi city. Address after change: Floor 16, PV Oil Building, 148 Hoang Quoc Viet, Nghia Tan ward, Cau Giay district, Ha Noi city.Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: ₫259 (vs ₫264 in 2Q 2021)Second quarter 2022 results: EPS: ₫259 (down from ₫264 in 2Q 2021). Revenue: ₫4.61t (up 41% from 2Q 2021). Net income: ₫84.6b (down 2.0% from 2Q 2021). Profit margin: 1.8% (down from 2.6% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₫11,900, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total loss to shareholders of 19% over the past three years.お知らせ • Jun 01An Phat Bioplastics Joint Stock Company, Annual General Meeting, Jun 20, 2022An Phat Bioplastics Joint Stock Company, Annual General Meeting, Jun 20, 2022, at 02:00 Coordinated Universal Time. Location: lot CN11-CN12, An Dong Industrial cluster Nam Sach town, Nam Sach district Hai Duong Province VietnamReported Earnings • May 02First quarter 2022 earnings released: EPS: ₫270 (vs ₫308 in 1Q 2021)First quarter 2022 results: EPS: ₫270. Revenue: ₫4.03t (up 76% from 1Q 2021). Net income: ₫88.1b (up 17% from 1Q 2021). Profit margin: 2.2% (down from 3.3% in 1Q 2021). The decrease in margin was driven by higher expenses.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Cuong Dinh was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 20Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₫14,300, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 14x in the Chemicals industry in Vietnam. Negligible returns to shareholders over past three years.お知らせ • Apr 06An Phat Bioplastics Joint Stock Company announced that it expects to receive VND 470 billion in fundingAn Phat Bioplastics Joint Stock Company announced that it will issue 470 bonds for gross proceeds of VND 470,000,000,000 on April 4, 2022.Reported Earnings • Feb 02Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: ₫872 (down from ₫1,191 in FY 2020). Revenue: ₫13t (up 77% from FY 2020). Net income: ₫284.5b (up 8.5% from FY 2020). Profit margin: 2.2% (down from 3.5% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.7%. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₫21,900, the stock trades at a trailing P/E ratio of 25.4x. Average forward P/E is 12x in the Chemicals industry in Vietnam. Total returns to shareholders of 90% over the past three years.Upcoming Dividend • Aug 25Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 01 September 2021. Payment date: 28 October 2021. Trailing yield: 5.6%. Lower than top quartile of Vietnamese dividend payers (7.4%). Higher than average of industry peers (2.5%).Reported Earnings • Aug 04Second quarter 2021 earnings releasedThe company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: ₫3.26t (up 80% from 2Q 2020). Net income: ₫83.4b (up 23% from 2Q 2020). Profit margin: 2.6% (down from 3.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • Jul 15An Phat Bioplastics Joint Stock Company announced that it expects to receive VND 296.75997 billion in fundingAn Phat Bioplastics Joint Stock Company announced a private placement of 29,675,997 shares at a price of VDN 10,000 per share for the gross proceeds of VDN 296,759,970,000 on July 13, 2021.Valuation Update With 7 Day Price Move • Jul 06Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₫17,300, the stock trades at a trailing P/E ratio of 13.8x. Average forward P/E is 16x in the Chemicals industry in Vietnam. Total returns to shareholders of 9.1% over the past three years.Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₫19,150, the stock trades at a trailing P/E ratio of 15.2x. Average forward P/E is 16x in the Chemicals industry in Vietnam. Total returns to shareholders of 12% over the past three years.お知らせ • May 06An Phat Bioplastics Joint Stock Company has completed a Follow-on Equity Offering in the amount of VND 1.0677 trillion.An Phat Bioplastics Joint Stock Company has completed a Follow-on Equity Offering in the amount of VND 1.0677 trillion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 75,000,000 Price\Range: VND 14236Price Target Changed • Mar 24Price target increased to ₫16,700Up from ₫14,600, the current price target is provided by 1 analyst. New target price is 6.4% above last closing price of ₫15,700. Stock is up 56% over the past year.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₫17,000, the stock trades at a trailing P/E ratio of 14.7x, up from the previous P/E ratio of 12.7x. Average P/E is 13x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years was a loss of 6.4%.Is New 90 Day High Low • Mar 11New 90-day high: ₫16,200The company is up 25% from its price of ₫12,950 on 11 December 2020. The Vietnamese market is up 15% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 25% over the same period.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₫12,200, the stock is trading at a trailing P/E ratio of 10.6x, down from the previous P/E ratio of 12.7x. This compares to an average P/E of 12x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years is a loss of 34%.Is New 90 Day High Low • Jan 04New 90-day high: ₫14,550The company is up 22% from its price of ₫11,952 on 06 October 2020. The Vietnamese market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.Is New 90 Day High Low • Dec 07New 90-day high: ₫12,950The company is up 7.0% from its price of ₫12,048 on 08 September 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₫7,619 per share.Is New 90 Day High Low • Nov 19New 90-day high: ₫12,300The company is up 5.0% from its price of ₫11,667 on 21 August 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₫7,796 per share.お知らせ • Oct 06An Phat Bioplastics Joint Stock Company Appoints Lam Thi Hien as Deputy Chief Executive OfficerThe Board resolution dated October 03, 2020, the BOD of An Phat Bioplastics Joint Stock Company approved to appoint Mrs. Lam Thi Hien as Deputy Chief Executive Officer of the Company from October 03, 2020.株主還元AAAVN ChemicalsVN 市場7D-1.1%-5.5%-2.1%1Y-2.2%13.5%41.3%株主還元を見る業界別リターン: AAA過去 1 年間で13.5 % の収益を上げたVN Chemicals業界を下回りました。リターン対市場: AAAは、過去 1 年間で41.3 % のリターンを上げたVN市場を下回りました。価格変動Is AAA's price volatile compared to industry and market?AAA volatilityAAA Average Weekly Movement3.8%Chemicals Industry Average Movement6.3%Market Average Movement5.0%10% most volatile stocks in VN Market8.0%10% least volatile stocks in VN Market2.9%安定した株価: AAA 、 VN市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: AAAの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20024,493Trung Nguyenanphatbioplastics.comAn Phat Bioplastics Joint Stock Company は、子会社とともにベトナム、シンガポール、米国、韓国、および国際的なプラスチック製品の生産と取引を行っている。生産活動、商業取引活動、工場・プラント取引、土地・工業団地インフラ賃貸、その他活動セグメントを通じて事業を展開している。同社は、プラスチック包装製品、堆肥化可能なクラフト紙、食品、ゴミ、ショッピング/ファッションバッグ、PEライナー、ストレッチ/農業用フィルム、ドローテープ、プラスチック袋、手袋、ナイフ、フォーク、ストローをAnEcoブランド名で提供している。また、添加剤や石粉の提供、工業団地のインフラの開発、リース、取引、プラスチックビーズの取引、道路や海上での商品の輸送、薄膜フィルムやその他のプラスチック製品への投資や取引、工場やプラントの取引、土地のリースも行っている。同社は以前はAn Phat Plastic And Green Environment Joint Stock Companyとして知られていたが、2019年4月にAn Phat Bioplastics Joint Stock Companyに社名を変更した。An Phat Bioplastics Joint Stock Companyは2002年に設立され、ベトナムのハイズンに本社を置いている。もっと見るAn Phat Bioplastics Joint Stock Company 基礎のまとめAn Phat Bioplastics の収益と売上を時価総額と比較するとどうか。AAA 基礎統計学時価総額₫2.77t収益（TTM）₫481.34b売上高(TTM)₫9.10t5.8xPER（株価収益率0.3xP/SレシオAAA は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計AAA 損益計算書（TTM）収益₫9.10t売上原価₫7.71t売上総利益₫1.39tその他の費用₫907.59b収益₫481.34b直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）1.22kグロス・マージン15.27%純利益率5.29%有利子負債／自己資本比率48.5%AAA の長期的なパフォーマンスは？過去の実績と比較を見る配当金4.3%現在の配当利回り32%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 23:02終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋An Phat Bioplastics Joint Stock Company 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関null nullBIDV Securities Joint Stock Companynull nullFPT SecuritiesChau Dao MinhSSI Securities Corporation
Reported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₫2.22t (down 42% from 1Q 2025). Net income: ₫153.7b (up 240% from 1Q 2025). Profit margin: 6.9% (up from 1.2% in 1Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Vietnam.
お知らせ • Apr 04An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026, at 09:00 SE Asia Standard Time. Location: head ofice - lot cni1+cn12, an dong industrial-, cluster, nam sach commune, hai phong city Vietnam
Reported Earnings • Jan 29Full year 2025 earnings released: EPS: ₫947 (vs ₫964 in FY 2024)Full year 2025 results: EPS: ₫947. Revenue: ₫11t (down 16% from FY 2024). Net income: ₫372.9b (up 1.2% from FY 2024). Profit margin: 3.5% (up from 2.9% in FY 2024). The increase in margin was driven by lower expenses.
Reported Earnings • Nov 01Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₫2.37t (down 26% from 3Q 2024). Net income: ₫117.6b (up 439% from 3Q 2024). Profit margin: 5.0% (up from 0.7% in 3Q 2024). The increase in margin was driven by lower expenses.
New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 4.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.0% net profit margin).
Reported Earnings • Jul 31Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: ₫2.31t (down 17% from 2Q 2024). Net income: ₫121.3b (down 11% from 2Q 2024). Profit margin: 5.3% (up from 4.9% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Reported Earnings • May 05First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: ₫2.22t (down 42% from 1Q 2025). Net income: ₫153.7b (up 240% from 1Q 2025). Profit margin: 6.9% (up from 1.2% in 1Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Vietnam.
お知らせ • Apr 04An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 07, 2026, at 09:00 SE Asia Standard Time. Location: head ofice - lot cni1+cn12, an dong industrial-, cluster, nam sach commune, hai phong city Vietnam
Reported Earnings • Jan 29Full year 2025 earnings released: EPS: ₫947 (vs ₫964 in FY 2024)Full year 2025 results: EPS: ₫947. Revenue: ₫11t (down 16% from FY 2024). Net income: ₫372.9b (up 1.2% from FY 2024). Profit margin: 3.5% (up from 2.9% in FY 2024). The increase in margin was driven by lower expenses.
Reported Earnings • Nov 01Third quarter 2025 earnings releasedThird quarter 2025 results: Revenue: ₫2.37t (down 26% from 3Q 2024). Net income: ₫117.6b (up 439% from 3Q 2024). Profit margin: 5.0% (up from 0.7% in 3Q 2024). The increase in margin was driven by lower expenses.
New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 4.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.0% net profit margin).
Reported Earnings • Jul 31Second quarter 2025 earnings releasedSecond quarter 2025 results: Revenue: ₫2.31t (down 17% from 2Q 2024). Net income: ₫121.3b (down 11% from 2Q 2024). Profit margin: 5.3% (up from 4.9% in 2Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
New Risk • Jun 01New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 4.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
Upcoming Dividend • May 23Upcoming dividend of ₫300 per shareEligible shareholders must have bought the stock before 30 May 2025. Payment date: 20 June 2025. The company last paid an ordinary dividend in June 2014. The average dividend yield among industry peers is 3.8%.
New Risk • May 01New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.0% Last year net profit margin: 3.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.
New Risk • Apr 09New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₫2.45t (US$93.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Apr 09Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₫6,410, the stock trades at a trailing P/E ratio of 6.6x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total loss to shareholders of 63% over the past three years.
お知らせ • Apr 09An Phat Bioplastics Joint Stock Company, Annual General Meeting, Apr 28, 2025An Phat Bioplastics Joint Stock Company, Annual General Meeting, Apr 28, 2025, at 09:00 SE Asia Standard Time. Location: lot cn11-, cn12 an dong industrial park, nam sach town, nam sach district, hai duong province., Vietnam
Reported Earnings • Apr 08Full year 2024 earnings released: EPS: ₫964 (vs ₫651 in FY 2023)Full year 2024 results: EPS: ₫964 (up from ₫651 in FY 2023). Revenue: ₫13t (up 1.3% from FY 2023). Net income: ₫368.6b (up 48% from FY 2023). Profit margin: 2.9% (up from 2.0% in FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
Reported Earnings • Jan 30Full year 2024 earnings released: EPS: ₫947 (vs ₫757 in FY 2023)Full year 2024 results: EPS: ₫947 (up from ₫757 in FY 2023). Revenue: ₫13t (up 1.3% from FY 2023). Net income: ₫361.8b (up 25% from FY 2023). Profit margin: 2.8% (up from 2.3% in FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 30Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: ₫3.19t (down 9.5% from 3Q 2023). Net income: ₫21.8b (down 78% from 3Q 2023). Profit margin: 0.7% (down from 2.8% in 3Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Sep 27Standing Deputy General Director recently sold ₫2.0b worth of stockOn the 20th of September, Thoan Tran sold around 200k shares on-market at roughly ₫10,000 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
お知らせ • Sep 12An Phat Bioplastics Joint Stock Company (HOSE:AAA) agreed to acquire additional 15.3% stake in Hanoi Plastics Joint Stock Company (HOSE:NHH) from An Phat Holdings Joint Stock Company (HOSE:APH).An Phat Bioplastics Joint Stock Company (HOSE:AAA) agreed to acquire additional 15.3% stake in Hanoi Plastics Joint Stock Company (HOSE:NHH) from An Phat Holdings Joint Stock Company (HOSE:APH) on September 10, 2024. An Phat Holdings Joint Stock Company is selling 11,160,308 shares of Hanoi Plastics Joint Stock Company. An Phat Bioplastics Joint Stock Company will hold 45,732,882 shares equivalent to 62.75% stake in Hanoi Plastics Joint Stock Company. The transaction has been approved by the board of An Phat Holdings Joint Stock Company and An Phat Bioplastics Joint Stock Company.
Reported Earnings • Aug 02Second quarter 2024 earnings releasedSecond quarter 2024 results: Revenue: ₫2.78t (flat on 2Q 2023). Net income: ₫119.4b (up 386% from 2Q 2023). Profit margin: 4.3% (up from 0.9% in 2Q 2023).
Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: ₫2.96t (down 18% from 1Q 2023). Net income: ₫134.7b (up 88% from 1Q 2023). Profit margin: 4.5% (up from 2.0% in 1Q 2023). The increase in margin was driven by lower expenses.
お知らせ • Apr 28An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 27, 2024An Phat Bioplastics Joint Stock Company, Annual General Meeting, May 27, 2024, at 02:00 Coordinated Universal Time. Location: Lot CN11-CN12, An Dong Industrial Cluster, Nam Sach town, Nam Sach disitrct Hai Duong Province Vietnam
Reported Earnings • Feb 02Full year 2023 earnings released: EPS: ₫761 (vs ₫433 in FY 2022)Full year 2023 results: EPS: ₫761 (up from ₫433 in FY 2022). Revenue: ₫13t (down 18% from FY 2022). Net income: ₫290.9b (up 91% from FY 2022). Profit margin: 2.3% (up from 1.0% in FY 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Reported Earnings • Nov 02Third quarter 2023 earnings releasedThird quarter 2023 results: Revenue: ₫3.53t (up 7.6% from 3Q 2022). Net income: ₫99.0b (up 24% from 3Q 2022). Profit margin: 2.8% (up from 2.4% in 3Q 2022). The increase in margin was driven by higher revenue.
Reported Earnings • Aug 03Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: ₫2.79t (down 39% from 2Q 2022). Net income: ₫43.0b (down 50% from 2Q 2022). Profit margin: 1.5% (down from 1.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 30First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: ₫3.62t (down 10% from 1Q 2022). Net income: ₫53.9b (down 39% from 1Q 2022). Profit margin: 1.5% (down from 2.2% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Feb 01Full year 2022 earnings released: EPS: ₫407 (vs ₫994 in FY 2021)Full year 2022 results: EPS: ₫407 (down from ₫994 in FY 2021). Revenue: ₫15t (up 16% from FY 2021). Net income: ₫155.7b (down 46% from FY 2021). Profit margin: 1.0% (down from 2.2% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Board Change • Nov 24No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Nghia Phan was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 25an Phat Bioplastics Joint Stock Company Announces Relocation of Representative OfficeOn August 22, 2022, the Board of Directors of An Phat Bioplastics Joint Stock Company approved the relocation of representative office as follows: Address before change: B9, No.6/106 Hoang Quoc Viet, Nghia Do ward, Cau Giay district, Ha Noi city. Address after change: Floor 16, PV Oil Building, 148 Hoang Quoc Viet, Nghia Tan ward, Cau Giay district, Ha Noi city.
Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: ₫259 (vs ₫264 in 2Q 2021)Second quarter 2022 results: EPS: ₫259 (down from ₫264 in 2Q 2021). Revenue: ₫4.61t (up 41% from 2Q 2021). Net income: ₫84.6b (down 2.0% from 2Q 2021). Profit margin: 1.8% (down from 2.6% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₫11,900, the stock trades at a trailing P/E ratio of 12.8x. Average trailing P/E is 11x in the Chemicals industry in Vietnam. Total loss to shareholders of 19% over the past three years.
お知らせ • Jun 01An Phat Bioplastics Joint Stock Company, Annual General Meeting, Jun 20, 2022An Phat Bioplastics Joint Stock Company, Annual General Meeting, Jun 20, 2022, at 02:00 Coordinated Universal Time. Location: lot CN11-CN12, An Dong Industrial cluster Nam Sach town, Nam Sach district Hai Duong Province Vietnam
Reported Earnings • May 02First quarter 2022 earnings released: EPS: ₫270 (vs ₫308 in 1Q 2021)First quarter 2022 results: EPS: ₫270. Revenue: ₫4.03t (up 76% from 1Q 2021). Net income: ₫88.1b (up 17% from 1Q 2021). Profit margin: 2.2% (down from 3.3% in 1Q 2021). The decrease in margin was driven by higher expenses.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 7 non-independent directors. Director Cuong Dinh was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₫14,300, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 14x in the Chemicals industry in Vietnam. Negligible returns to shareholders over past three years.
お知らせ • Apr 06An Phat Bioplastics Joint Stock Company announced that it expects to receive VND 470 billion in fundingAn Phat Bioplastics Joint Stock Company announced that it will issue 470 bonds for gross proceeds of VND 470,000,000,000 on April 4, 2022.
Reported Earnings • Feb 02Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: ₫872 (down from ₫1,191 in FY 2020). Revenue: ₫13t (up 77% from FY 2020). Net income: ₫284.5b (up 8.5% from FY 2020). Profit margin: 2.2% (down from 3.5% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.7%. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 27Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₫21,900, the stock trades at a trailing P/E ratio of 25.4x. Average forward P/E is 12x in the Chemicals industry in Vietnam. Total returns to shareholders of 90% over the past three years.
Upcoming Dividend • Aug 25Upcoming dividend of ₫500 per shareEligible shareholders must have bought the stock before 01 September 2021. Payment date: 28 October 2021. Trailing yield: 5.6%. Lower than top quartile of Vietnamese dividend payers (7.4%). Higher than average of industry peers (2.5%).
Reported Earnings • Aug 04Second quarter 2021 earnings releasedThe company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: ₫3.26t (up 80% from 2Q 2020). Net income: ₫83.4b (up 23% from 2Q 2020). Profit margin: 2.6% (down from 3.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • Jul 15An Phat Bioplastics Joint Stock Company announced that it expects to receive VND 296.75997 billion in fundingAn Phat Bioplastics Joint Stock Company announced a private placement of 29,675,997 shares at a price of VDN 10,000 per share for the gross proceeds of VDN 296,759,970,000 on July 13, 2021.
Valuation Update With 7 Day Price Move • Jul 06Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₫17,300, the stock trades at a trailing P/E ratio of 13.8x. Average forward P/E is 16x in the Chemicals industry in Vietnam. Total returns to shareholders of 9.1% over the past three years.
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₫19,150, the stock trades at a trailing P/E ratio of 15.2x. Average forward P/E is 16x in the Chemicals industry in Vietnam. Total returns to shareholders of 12% over the past three years.
お知らせ • May 06An Phat Bioplastics Joint Stock Company has completed a Follow-on Equity Offering in the amount of VND 1.0677 trillion.An Phat Bioplastics Joint Stock Company has completed a Follow-on Equity Offering in the amount of VND 1.0677 trillion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 75,000,000 Price\Range: VND 14236
Price Target Changed • Mar 24Price target increased to ₫16,700Up from ₫14,600, the current price target is provided by 1 analyst. New target price is 6.4% above last closing price of ₫15,700. Stock is up 56% over the past year.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₫17,000, the stock trades at a trailing P/E ratio of 14.7x, up from the previous P/E ratio of 12.7x. Average P/E is 13x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years was a loss of 6.4%.
Is New 90 Day High Low • Mar 11New 90-day high: ₫16,200The company is up 25% from its price of ₫12,950 on 11 December 2020. The Vietnamese market is up 15% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 25% over the same period.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₫12,200, the stock is trading at a trailing P/E ratio of 10.6x, down from the previous P/E ratio of 12.7x. This compares to an average P/E of 12x in the Chemicals industry in Vietnam. Total return to shareholders over the past three years is a loss of 34%.
Is New 90 Day High Low • Jan 04New 90-day high: ₫14,550The company is up 22% from its price of ₫11,952 on 06 October 2020. The Vietnamese market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Dec 07New 90-day high: ₫12,950The company is up 7.0% from its price of ₫12,048 on 08 September 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₫7,619 per share.
Is New 90 Day High Low • Nov 19New 90-day high: ₫12,300The company is up 5.0% from its price of ₫11,667 on 21 August 2020. The Vietnamese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₫7,796 per share.
お知らせ • Oct 06An Phat Bioplastics Joint Stock Company Appoints Lam Thi Hien as Deputy Chief Executive OfficerThe Board resolution dated October 03, 2020, the BOD of An Phat Bioplastics Joint Stock Company approved to appoint Mrs. Lam Thi Hien as Deputy Chief Executive Officer of the Company from October 03, 2020.
